Moreover, some apoptosis-related proteins have been associated with melanoma sensitivity to BRAF and MEK inhibitors, such as the Bcl2-interacting killer (BIK) protein that mediates on BRAF inhibitor effectiveness [146] and Survivin that contributes to melanoma cells survival by inhibiting apoptosis [147]. The gene discussed is MAP2K7; the disease is melanoma.